Literature DB >> 26267517

Activating Mutations in PIK3CA Lead to Widespread Modulation of the Tyrosine Phosphoproteome.

Muhammad Saddiq Zahari1, Xinyan Wu1, Brian G Blair2, Sneha M Pinto3, Raja S Nirujogi3, Christine A Jelinek1, Radhika Malhotra4, Min-Sik Kim1, Ben Ho Park2, Akhilesh Pandey1,5.   

Abstract

The human oncogene PIK3CA is frequently mutated in human cancers. Two hotspot mutations in PIK3CA, E545K and H1047R, have been shown to regulate widespread signaling events downstream of AKT, leading to increased cell proliferation, growth, survival, and motility. We used quantitative mass spectrometry to profile the global phosphotyrosine proteome of isogenic knock-in cell lines containing these activating mutations, where we identified 824 unique phosphopeptides. Although it is well understood that these mutations result in hyperactivation of the serine/threonine kinase AKT, we found a surprisingly widespread modulation of tyrosine phosphorylation levels of proteins in the mutant cells. In the tyrosine kinome alone, 29 tyrosine kinases were altered in their phosphorylation status. Many of the regulated phosphosites that we identified were located in the kinase domain or the canonical activation sites, indicating that these kinases and their downstream signaling pathways were activated. Our study demonstrates that there is frequent and unexpected cross-talk that occurs between tyrosine signaling pathways and serine/threonine signaling pathways activated by the canonical PI3K-AKT axis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26267517      PMCID: PMC4641567          DOI: 10.1021/acs.jproteome.5b00302

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  39 in total

Review 1.  The conformational plasticity of protein kinases.

Authors:  Morgan Huse; John Kuriyan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

Review 2.  Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model?

Authors:  Joseph A Adams
Journal:  Biochemistry       Date:  2003-01-28       Impact factor: 3.162

3.  Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.

Authors:  Olga A Guryanova; Qiulian Wu; Lin Cheng; Justin D Lathia; Zhi Huang; Jinbo Yang; Jennifer MacSwords; Christine E Eyler; Roger E McLendon; John M Heddleston; Weinian Shou; Dolores Hambardzumyan; Jeongwu Lee; Anita B Hjelmeland; Andrew E Sloan; Markus Bredel; George R Stark; Jeremy N Rich; Shideng Bao
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

4.  Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.

Authors:  Wei-Chien Huang; Yun-Ju Chen; Long-Yuan Li; Ya-Ling Wei; Sheng-Chieh Hsu; Shing-Ling Tsai; Pei-Chun Chiu; Wei-Pang Huang; Ying-Nai Wang; Chung-Hsuan Chen; Wei-Chao Chang; Wen-Chang Chang; Andy Jer-En Chen; Chang-Hai Tsai; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

5.  Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells.

Authors:  Yuexi Wang; Feng Yang; Marina A Gritsenko; Yingchun Wang; Therese Clauss; Tao Liu; Yufeng Shen; Matthew E Monroe; Daniel Lopez-Ferrer; Theresa Reno; Ronald J Moore; Richard L Klemke; David G Camp; Richard D Smith
Journal:  Proteomics       Date:  2011-04-18       Impact factor: 3.984

6.  Insulin receptor tyrosine kinase activity and phosphorylation of tyrosines 1162 and 1163 are required for insulin-increased prolactin gene expression.

Authors:  Kirsten K Jacob; Jonathan Whittaker; Frederick M Stanley
Journal:  Mol Cell Endocrinol       Date:  2002-01-15       Impact factor: 4.102

7.  Essential role of Stat3 in PI3K-induced oncogenic transformation.

Authors:  Jonathan R Hart; Lujian Liao; John R Yates; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

8.  EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.

Authors:  Hui Miao; Da-Qiang Li; Amitava Mukherjee; Hong Guo; Aaron Petty; Jennifer Cutter; James P Basilion; John Sedor; Jiong Wu; David Danielpour; Andrew E Sloan; Mark L Cohen; Bingcheng Wang
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

9.  Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity.

Authors:  Elad Hikri; Sally Shpungin; Uri Nir
Journal:  Cell Signal       Date:  2008-12-30       Impact factor: 4.315

10.  Knockin of mutant PIK3CA activates multiple oncogenic pathways.

Authors:  John P Gustin; Bedri Karakas; Michele B Weiss; Abde M Abukhdeir; Josh Lauring; Joseph P Garay; David Cosgrove; Akina Tamaki; Hiroyuki Konishi; Yuko Konishi; Morassa Mohseni; Grace Wang; D Marc Rosen; Samuel R Denmeade; Michaela J Higgins; Michele I Vitolo; Kurtis E Bachman; Ben Ho Park
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

View more
  6 in total

1.  Linking invasive motility to protein expression in single tumor cells.

Authors:  Jung-Ming G Lin; Chi-Chih Kang; Yun Zhou; Haiyan Huang; Amy E Herr; Sanjay Kumar
Journal:  Lab Chip       Date:  2018-01-16       Impact factor: 6.799

2.  Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. elegans.

Authors:  Christopher J Mitchell; Min-Sik Kim; Jun Zhong; Raja Sekhar Nirujogi; Anjun K Bose; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2016-03-25       Impact factor: 6.603

3.  Mapping Keratoconus Molecular Substrates by Multiplexed High-Resolution Proteomics of Unpooled Corneas.

Authors:  Vishal Shinde; Nan Hu; Santosh Renuse; Alka Mahale; Akhilesh Pandey; Charles Eberhart; Donald Stone; Samar A Al-Swailem; Azza Maktabi; Shukti Chakravarti
Journal:  OMICS       Date:  2019-10-25

4.  Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.

Authors:  Maxim Ivanov; Konstantin Laktionov; Valery Breder; Polina Chernenko; Ekaterina Novikova; Ekaterina Telysheva; Sergey Musienko; Ancha Baranova; Vladislav Mileyko
Journal:  J Transl Med       Date:  2017-01-31       Impact factor: 5.531

5.  Correlation between PIK3CA mutations in cell-free DNA and everolimus efficacy in HR+, HER2- advanced breast cancer: results from BOLERO-2.

Authors:  Mary Ellen Moynahan; David Chen; Wei He; Patricia Sung; Aliaksandra Samoila; Daoqi You; Trusha Bhatt; Parul Patel; Francois Ringeisen; Gabriel N Hortobagyi; Jose Baselga; Sarat Chandarlapaty
Journal:  Br J Cancer       Date:  2017-02-09       Impact factor: 7.640

6.  Quantitative Tyrosine Phosphoproteomic Analysis of Resistance to Radiotherapy in Nasopharyngeal Carcinoma Cells.

Authors:  Lin Shen; Zhanzhan Li; Liangfang Shen
Journal:  Cancer Manag Res       Date:  2020-12-09       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.